5 Stocks Pushing The Health Services Industry Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 57 points (-0.4%) at 13,961 as of Wednesday, Feb. 13, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,624 issues advancing vs. 1,238 declining with 155 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Humana ( HUM), down 1.5%, and Edwards Life ( EW), down 1.0%. Top gainers within the industry include HCA Holdings ( HCA), up 1.3%, Express Scripts ( ESRX), up 0.8%, Fresenius Medical Care Corporation ( FMS), up 0.6% and Thermo Fisher Scientific ( TMO), up 0.6%.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today:

5. Cigna ( CI) is one of the companies pushing the Health Services industry lower today. As of noon trading, Cigna is down $0.49 (-0.8%) to $61.49 on light volume Thus far, 568,770 shares of Cigna exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $61.49-$62.14 after having opened the day at $62.12 as compared to the previous trading day's close of $61.98.

CIGNA Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $17.7 billion and is part of the health care sector. The company has a P/E ratio of 10.3, below the S&P 500 P/E ratio of 17.7. Shares are up 15.7% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Cigna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, attractive valuation levels, solid stock price performance and impressive record of earnings per share growth. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Cigna Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Healthcare Management Stocks Look Too Pricey for Activists

The Stock That Crashed 25% Overnight Has a Lesson to Teach Us: Market Recon